Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo

Oral Oncology

Volumn 45, Issue 7, 2009, Pages 562-568

  Chen, Yuan Wu ^a,b   Lin, Gu Jiun ^a   Chia, Wei Tso ^a   Lin, Chih Kung ^b   Chuang, Yi Ping ^a   Sytwu, Huey Kang ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Oral squamous cell carcinoma; Triptolide

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; TRIPTOLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN KB; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH CANCER; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; DITERPENES; DRUG SCREENING ASSAYS, ANTITUMOR; EPOXY COMPOUNDS; HUMANS; KB CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MOUTH NEOPLASMS; PHENANTHRENES;

EID: 67549087949     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.10.007     Document Type: Article

References (34)

1. Chen Y.J., Lin S.C., Kao T., et al. Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204 3 (2004) 326-332
2. Pentenero M., Gandolfo S., and Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 27 12 (2005) 1080-1091
3. Lo W.L., Kao S.Y., Chi L.Y., Wong Y.K., and Chang R.C. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 61 7 (2003) 751-758
4. McCarty M.F. Current prospects for controlling cancer growth with non-cytotoxic agents-nutrients, phytochemicals, herbal extracts, and available drugs. Med Hypotheses 56 2 (2001) 137-154
5. Kupchan S.M., Court W.A., Dailey Jr. R.G., Gilmore C.J., and Bryan R.F. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc 94 20 (1972) 7194-7195
6. Qiu D., and Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook F. Drugs RD 4 1 (2003) 1-18
7. Qiu D., Zhao G., Aoki Y., et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 274 19 (1999) 13443-13450
8. Qin W.Z., Zhu G.D., Yang S.M., Han K.Y., and Wang J. Clinical observations on Tripterygium wilfordii in treatment of 26 cases of discoid lupus erythematosus. J Tradit Chin Med 3 2 (1983) 131-132
9. Tao X.L., Sun Y., Dong Y., et al. A prospective, controlled, double-blind, cross-over study of Tripterygium wilfodii Hook F in treatment of rheumatoid arthritis. Chin Med J (Engl) 102 5 (1989) 327-332
10. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 8 8 (2002) 2666-2674
11. Krishna G., Liu K., Shigemitsu H., Gao M., Raffin T.A., and Rosen G.D. PG490-88, a derivative of triptolide, blocks bleomycin-induced lung fibrosis. Am J Pathol 158 3 (2001) 997-1004
12. Lee H.H., Dadgostar H., Cheng Q., Shu J., and Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 96 16 (1999) 9136-9141
13. Chang W.T., Kang J.J., Lee K.Y., et al. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem 276 3 (2001) 2221-2227
14. Carter B.Z., Mak D.H., Schober W.D., et al. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 108 2 (2006) 630-637
15. Yang S., Chen J., Guo Z., et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2 1 (2003) 65-72
16. Finlay G.J., Baguley B.C., and Wilson W.R. A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal Biochem 139 2 (1984) 272-277
17. Kuo C.C., Hsieh H.P., Pan W.Y., et al. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Cancer Res 64 13 (2004) 4621-4628
18. Kim B.R., Shim J.W., Sung D.K., et al. Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. Yonsei Med J 49 5 (2008) 836-842
19. Lin J., Chen L.Y., Lin Z.X., and Zhao M.L. The effect of triptolide on apoptosis of glioblastoma multiforme (GBM) cells. J Int Med Res 35 5 (2007) 637-643
20. Tengchaisri T., Chawengkirttikul R., Rachaphaew N., Reutrakul V., Sangsuwan R., and Sirisinha S. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett 133 2 (1998) 169-175
21. Krysko D.V., Vanden Berghe T., D'Herde K., and Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 44 3 (2008) 205-221
22. Krysko D.V., D'Herde K., and Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11 10 (2006) 1709-1726
23. Engels I.H., Stepczynska A., Stroh C., et al. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 19 40 (2000) 4563-4573
24. von Haefen C., Wieder T., Essmann F., Schulze-Osthoff K., Dorken B., and Daniel P.T. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene 22 15 (2003) 2236-2247
25. Juang S.H., Pan W.Y., Kuo C.C., et al. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Biochem Pharmacol 68 2 (2004) 293-303
26. Liu X., Zhou B., Xue L., et al. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells. Clin Cancer Res 12 21 (2006) 6337-6344
27. Kim M.S., Li S.L., Bertolami C.N., Cherrick H.M., and Park N.H. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res 13 5A (1993) 1405-1413
28. Kamiya Y., and Ohshima T. The Individual Cell Properties of Oral Squamous Cell Carcinoma and p53 Tumor Suppressor Gene Mutation. Oral Sci Int 2 2 (2005) 104-117
29. Wang X., Matta R., Shen G., Nelin L.D., Pei D., and Liu Y. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide. J Mol Med 84 5 (2006) 405-415
30. Wan C.K., Wang C., Cheung H.Y., Yang M., and Fong W.F. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells. Cancer Lett 241 1 (2006) 31-41
31. Kuzuya K. Chemoradiotherapy for uterine cancer: current status and perspectives. Int J Clin Oncol 9 6 (2004) 458-470
32. Psyrri A., and Fountzilas G. Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region. Med Oncol 23 1 (2006) 1-15
33. Tang X.Y., Zhu Y.Q., Tao W.H., Wei B., and Lin X.L. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma. Postgrad Med J 83 979 (2007) 338-343
34. Wang W., Yang S., Su Y., et al. Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res 13 16 (2007) 4891-4899